Top news of the week: 02.06.2020.
#BioTech #coronavirus #stocks #covid19 #healthcare
Healthcare
A biotech company tries to retrofit a lung drug for Covid-19 after effects #BioTech via https://t.co/2sI0UxJbpn https://t.co/6zjgqwA4nI
OpenA biotech company tries to retrofit a lung drug to prevent Covid-19’s after effects
PureTech Health, a biotech company in Boston, believes it might have a treatment for Covid-19 survivors facing the risk of long-term lung injuries.
RT @matthewherper: Moderna executives have cashed out $89M in shares this year. Some no longer hold $MRNA stock, @damiangarde writes. https://t.co/y7wbfJzTLb
OpenModerna executives have cashed out $89M in shares this year, as stock price has soared on vaccine hopes
With the firm in the spotlight for its Covid-19 vaccine, five executives have initiated nearly three times as many stock transactions than in all of 2019.
Small-Cap Pharma Fast-Tracking Repurposed Drug for Covid-19: https://t.co/97rLj2LojY
Algernon Pharmaceuticals is quickly moving ahead with a multinational Phase 2b/3 trial for Ifenprodil.
$AGN.CA $AGNPF #covid19 #biotech #healthcare #stocks @AlgernonPharma https://t.co/QsHZuhC0a2
OpenSmall-Cap Pharma Fast-Tracking Repurposed Drug for Covid-19
Algernon Pharmaceuticals is quickly moving ahead with a multinational Phase 2b/3 trial for Ifenprodil.
Under The Radar Biotech With Impressive Data #BioTech via https://t.co/2sI0UxJbpn https://t.co/5kyaPOVaNf
OpenPancreatic Cancer Drugs Market Future Prospects 2026 | Eli Lilly and Company, Celgene, Roche, Novartis
In addition, there’s still an unmet medical need for patients with locally advanced, inoperable pancreatic cancer (LAPC). In fact, PharmaCyte Biotech (PMCB) is hoping to change …
RT @lisamjarvis: Denali is out with 2 papers showing (in mice & monkeys) that their transport vehicle technology might just allow its drugs--including their lead Hunter syndrome candidate--to sneak by the always vexing blood-brain barrier. My look at $DNLI's science: https://t.co/jgc89zZgq9
OpenDenali Therapeutics unveils blood-brain barrier delivery system
A clinical trial for the first drug using the biotech firm’s transport vehicle, an enzyme replacement therapy for Hunter syndrome, is expected to start soon
US Biotech Firm Slammed for 'Dodgy Stock Offer Timed to Clinical Trial Results on COVID-19 Vaccine' #BioTech via https://t.co/2sI0UxJbpn https://t.co/z0T8WCNdk4
OpenUS Biotech Firm Slammed for 'Dodgy Stock Offer Timed to Clinical Trial Results on COVID-19 Vaccine'
US biotech company Moderna announced on 18 May that results of its first phase of clinical trials involving humans showed that patients given its potential COVID-19...
RT @PaulAndreola: Biotech: Who Will Survive When The COVID-19 Hype Ends? $IPA.V $IPATF https://t.co/PWjEzlTInA
OpenBiotech: Who Will Survive When The COVID-19 Hype Ends?
Over the last couple of months, companies have found a way to muster up an effort to align their objectives
COVID-19 vaccine development moving positively #BioTech via https://t.co/2sI0UxJbpn https://t.co/4IdIB6ShZP
OpenCOVID-19 vaccine development moving positively: Bharat Biotech
India witnessed 8,390 cases in 24 hours on the second consecutive day. The total case count of coronavirus disease mounted to 1,90,535 on Monday.